Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-27 @ 2:39 AM
Study NCT ID:
NCT04358393
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2020-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APG115AU101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None